App note – Light scattering measurements for biologics

The ability to monitor biologic candidates’ propensity towards self-association is critical for predicting whether a therapeutic is likely to aggregate or become difficult to administer due to viscosity.

In this app note, read how Merck KGaA uses light scattering measurements to predict how formulations will behave at clinically relevant concentrations and find the optimal formulation buffer for their biologics candidates.

You’ll learn about:

  • How Merck KGaA uses data from DLS and SLS to rank their candidates for improved downstream success
  • Prometheus Panta, an instrument that combines nanoDSF, DLS, and SLS for precise characterization of biologics
  • How data from the Prometheus Panta instrument compares with other systems

Access the app note here

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free